Lucid Diagnostics
Highly Engaged Employees
Manufacturing · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
360 Madison Ave Fl 25, New York, New Yor...Phone Number
(888) 582-4339Website
www.luciddx.comRevenue
$5.5 MillionStock Symbol
LUCDIndustry
About Lucid Diagnostics
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics company focused on improving the early detection of esophageal precancer and cancer. The company develops and commercializes diagnostic technologies intended to help healthcare professionals identify patients who may be at risk of developing serious esophageal diseases. Its business addresses an important clinical challenge: detecting potentially dangerous abnormalities before they progress to advanced cancer, when treatment options may become more limited and outcomes may be less favorable. The company concentrates on esophageal adenocarcinoma, an aggressive form of cancer that can develop in association with Barrett’s esophagus and other underlying risk factors. Gastroesophageal reflux disease.Explore more
SIC Code 38,384NAICS Code 33,339Ticker NASDAQ:LUCDShow moreLucid Diagnostics Org Chart
Compare Similar Companies to Lucid Diagnostics
Compare insights from companies similar to Lucid Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$40.1M
51-200
Private
-
2008
MM
Mariam MaghribiShifamed Chief Business Officer & President & CEO, Atia Vision & Tioga Cardiovascular
Lucid Diagnostics Tech Stack
A closer look at the technologies used by Lucid Diagnostics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lucid Diagnostics
Sign Up For FreeTo access detailed company insights
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics company focused on improving the early detection of esophageal precancer and cancer. The company develops and commercializes diagnostic technologies intended to help healthcare professionals identify patients who may be at risk of developing serious esophageal diseases. Its business a... Read More